1. Chemoprotection against three modes of radiation death in mice;Yuhas;Int. J. Radiat. Biol.,1969
2. J.M. Yuhas, On the potential application of radioprotective drugs in solid tumor therapy, in: G.H. Sokol, R.P. Marckel (Eds.), Radiation Drug Interaction in the Treatment of Cancer, John Wiley, New York, 1980, pp. 113–135.
3. Studies on toxic effect of WR-2721 in mouse;Uma Devi;Ind. J. Med. Sci.,1984
4. Clastogenetic effect of WR-2721 on mouse chromosomes;Uma Devi;Curr. Sci.,1985
5. A.T. Turrisi, M.M. Kligerman, D.J. Glover, H.H. Glick, L. Norfleet, M. Gramouski, Experience with Phase I trials of WR-2721 preceding radiation therapy, in: O.F. Nygaard, M.G. Simic (Eds.), Radioprotectors and Anticarcinogens, Academic Press, New York, 1983, pp. 681–694.